Literature DB >> 16771871

Extended right split liver graft for primary transplantation in children and adults.

Vittorio Corno1, Michele Colledan, Maria Clara Dezza, Michela Guizzetti, Alessandro Lucianetti, Gregorio Maldini, Domenico Pinelli, Mara Giovanelli, Marco Zambelli, Giuliano Torre, Mario Strazzabosco.   

Abstract

Skepticism remains about the use of the extended right (ER) split graft (segments I, IV-VIII) for adult liver transplantation. We analyzed the results of primary liver transplantation performed with an ER graft in adult and in pediatric recipients. At our Institution, between October 1997 and June 2005, 32 primary liver transplantations with an ER graft were performed in 22 adult and 10 pediatric recipients. All the splitting procedures were performed in situ. Actuarial patient and graft survival among the adult recipients of the ER graft were 100% and 100% at 1 year, and 94% and 94% at 5 years. In the pediatric recipients, patient and graft survival were 90% and 79% both at 1 and 5 years. No hepatic artery thrombosis (HAT) occurred in the adult group, while in the pediatric recipients HAT occurred in two cases. A higher biliary morbidity occurred in the ER graft group when compared with the whole size graft 34% versus 13% (P = 0.03). However, this did not affect patient and graft survival. The results of this study may represent a further argument in favor of extensive splitting of all suitable grafts.

Entities:  

Mesh:

Year:  2006        PMID: 16771871     DOI: 10.1111/j.1432-2277.2006.00323.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

Review 1.  Current status and perspectives in split liver transplantation.

Authors:  Andrea Lauterio; Stefano Di Sandro; Giacomo Concone; Riccardo De Carlis; Alessandro Giacomoni; Luciano De Carlis
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Methods to decrease blood loss and transfusion requirements for liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Theodora Pissanou; Hynek Pikhart; Jessica Vaughan; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

3.  A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients.

Authors:  Fuat Hakan Saner; Knut Nowak; Dieter Hoyer; Peter Rath; Ali Canbay; Andreas Paul; Michael Koldehoff; Ahmet Elmaağaclı
Journal:  BMC Gastroenterol       Date:  2014-01-06       Impact factor: 3.067

4.  Long-term results after adult ex situ split liver transplantation since its introduction in 1987.

Authors:  Harald Schrem; Moritz Kleine; Tim Oliver Lankisch; Alexander Kaltenborn; Lampros Kousoulas; Lea Zachau; Frank Lehner; Jürgen Klempnauer
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

5.  Liberal Use of Interposition Grafts for Arterial Reconstruction Is Safe and Effective in Adult Split Liver Transplantation.

Authors:  Ngee-Soon Lau; Ken Liu; Abdullah Almoflihi; Josephine Xu; Geoffrey McCaughan; Michael Crawford; Carlo Pulitano
Journal:  Transplant Direct       Date:  2021-07-23

Review 6.  Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis; Clare D Toon; Brian R Davidson; Andrew K Burroughs
Journal:  Cochrane Database Syst Rev       Date:  2013-12-02

Review 7.  Ischaemic preconditioning for liver transplantation.

Authors:  K S Gurusamy; Y Kumar; D Sharma; B R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 8.  Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.

Authors:  Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis; Clare D Toon; Elias Xirouchakis; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2013-12-04

Review 9.  Split liver transplantation in adults.

Authors:  Koji Hashimoto; Masato Fujiki; Cristiano Quintini; Federico N Aucejo; Teresa Diago Uso; Dympna M Kelly; Bijan Eghtesad; John J Fung; Charles M Miller
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.